Early Phase 1 Multiple Sclerosis Trial, Recruiting (NCT04390009)

Early Phase 1 Multiple Sclerosis Trial, Recruiting NCT04390009 Sponsor: Brain Health Alliance Condition: Multiple Sclerosis

Printed from Voxsanity (voxsanity.com.au) — NCT04390009 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Multiple Sclerosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis (MS) by a qualified neurologist who specializes in MS care.
Healthy individuals with no known medical conditions are also welcome to participate.
You must be able to lie still on a scanning bed for at least 10 minutes and up to 20 minutes during a PET-CT scan (a type of medical imaging scan).

Who may not be able to join:

People who have other serious medical or mental health conditions that are not related to MS, especially if those conditions were diagnosed before their MS symptoms first began.
People who are currently pregnant or breastfeeding.
People who have diabetes or other conditions affecting their metabolism or hormones.
People who currently have an active infection of any kind.
People who have a history of cancer that has spread to other parts of the body or grown into nearby tissues.
People who have recently had surgery, chemotherapy, or radiation therapy (confirm with trial site for exact timeframes).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Carl Taswell, MD, PhD, Brain Health Alliance

Phone: 949-481-3121

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04390009

Sponsor: Brain Health Alliance

Phase: Early Phase 1

Status: Recruiting

Condition: Multiple Sclerosis

Trial contact: 949-481-3121

More information: https://clinicaltrials.gov/study/NCT04390009

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with multiple sclerosis (MS) by a qualified neurologist who specializes in MS care.
Healthy individuals with no known medical conditions are also welcome to participate.
You must be able to lie still on a scanning bed for at least 10 minutes and up to 20 minutes during a PET-CT scan (a type of medical imaging scan).

Who may not be able to join:

People who have other serious medical or mental health conditions that are not related to MS, especially if those conditions were diagnosed before their MS symptoms first began.
People who are currently pregnant or breastfeeding.
People who have diabetes or other conditions affecting their metabolism or hormones.
People who currently have an active infection of any kind.
People who have a history of cancer that has spread to other parts of the body or grown into nearby tissues.
People who have recently had surgery, chemotherapy, or radiation therapy (confirm with trial site for exact timeframes).

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

Brain Health Alliance

Registry

ClinicalTrials.gov

Start date

30 September 2024

Est. completion

30 September 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Entire-body PET imaging of demyelination of peripheral and central nervous system; Psychometric questionnaire for monitoring psychological health

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov